中东和非洲类器官市场预测至2030年 - 区域分析 - 按器官类型(肠、肝、胃、胰腺、肺、脑、肾等)、应用(生物疾病的发展、传染病病理学、再生医学、药物发现和个性化医疗、药物毒性和功效测试等)、来源(多能干细胞和器官特异性成体干细胞)和类型(仪器、耗材和服务)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 90    |    Report Code: TIPRE00018855    |    Category: Life Sciences

Middle East & Africa Organoids Market

中东和中东地区非洲类器官市场预计将从2022年的6644万美元增长到2030年的2.4534亿美元。预计2022年至2030年复合年增长率为17.7%。

将类器官与芯片器官相结合,为中东和非洲地区提供燃料。非洲类器官市场

类器官和芯片上的器官作为不断发展的病理和人类生理相关的体外模型,有可能彻底改变癌症研究的传统范式并产生真正的临床效益。最近,类器官与芯片器官和 3D 生物打印的协作应用的趋势使得能够开发复杂的癌症模型来研究肿瘤-基质相互作用、多器官肿瘤转移和癌症-微环境相互作用的潜在机制。通过将多个类器官整合到芯片器官中,芯片类器官可以继承类器官和芯片器官的优点,并为研究多器官肿瘤转移和癌症微环境相互作用提供有价值的工具。

此外,技术进步将促进类器官与芯片器官相结合,促进疾病建模和临床药物筛选在生物和生物医学领域的各种应用。技术进步促进了脑类器官芯片、肝脏类器官芯片、肠道类器官芯片等的开发。尽管芯片类器官目前是一个发展中的领域,但仍有很大的改进空间。因此,还需要跨学科研究人员的共同努力,以实现类器官在人类生物医学研究中的充分利用,并引领未来市场的增长。

中东及非洲类器官市场概况

中东和非洲非洲类器官市场分为阿联酋、南非、沙特阿拉伯以及中东和非洲其他地区。非洲。该区域的增长归因于对癌症和基因突变的研究不断增长、疾病模型的增加以及提供类器官的市场参与者的发展。发展医疗设施、组织会议分享与干细胞技术相关的关键事实以及增加与外国实体的合作伙伴关系等因素可能会进一步推动 2022-2030 年市场增长。

中东和中东地区非洲类器官市场收入和 2030 年预测(百万美元)

中东和非洲非洲类器官市场细分

中东和非洲非洲类器官市场分为器官类型、类型、应用、来源和国家。

基于< /span>器官类型,中东和中东地区非洲类器官市场分为肠、肝、胃、胰腺、肺、脑、肾等。肠道部分在中东和非洲地区占据最大份额。 2022 年非洲类器官市场。

根据类型,中东和非洲非洲类器官市场分为仪器、消耗品和服务。 2022 年,消耗品细分市场在北美类器官市场中占据最大份额。

根据应用情况,中东和非洲地区将占据最大份额。非洲类器官市场细分为发育生物学疾病、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个性化医疗等。发育生物学疾病领域在中东和非洲地区占据最大份额。 2022 年非洲类器官市场。

根据消息来源,中东和非洲非洲类器官市场分为多能干细胞和器官特异性成体干细胞。多能干细胞细分市场在中东和非洲地区占有较大份额。 2022 年非洲类器官市场。

基于国家、中东和非洲地区非洲类器官市场分为int南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区。非洲。中东其他地区和非洲主导了中东和非洲2022 年非洲类器官市场。

Cellesce、InSphero、Merck KGaA、STEMCELL Technologies Inc 和 Thermo Fisher Scientific Inc 是在非洲运营的一些领先公司中东和非洲类器官市场。   



Middle East & Africa Organoids Strategic Insights

Strategic insights for Middle East & Africa Organoids involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-organoids-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Organoids Report Scope

Report Attribute Details
Market size in 2022 US$ 66.44 Million
Market Size by 2030 US$ 245.34 Million
Global CAGR (2022 - 2030) 17.7%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 器官类型
  • 肠
  • 肝
  • 胃
  • 胰腺
  • 肺
  • 脑
  • 肾
By 应用
  • 生物疾病研发
  • 传染病病理学
  • 再生医学
  • 药物研发及个性化医疗
  • 药物毒性及疗效测试
By 来源
  • 多能干细胞
  • 器官特异性成体干细胞
By 类型
  • 仪器
  • 耗材
  • 服务
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Cellesce
  • InSphero
  • Merck KGaA
  • STEMCELL Technologies Inc
  • Thermo Fisher Scientific Inc
  • Get more information on this report

    Middle East & Africa Organoids Regional Insights

    The regional scope of Middle East & Africa Organoids refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-organoids-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Organoids Market

    1. Cellesce
    2. InSphero
    3. Merck KGaA
    4. STEMCELL Technologies Inc
    5. Thermo Fisher Scientific Inc
    Frequently Asked Questions
    How big is the Middle East & Africa Organoids Market?

    The Middle East & Africa Organoids Market is valued at US$ 66.44 Million in 2022, it is projected to reach US$ 245.34 Million by 2030.

    What is the CAGR for Middle East & Africa Organoids Market by (2022 - 2030)?

    As per our report Middle East & Africa Organoids Market, the market size is valued at US$ 66.44 Million in 2022, projecting it to reach US$ 245.34 Million by 2030. This translates to a CAGR of approximately 17.7% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Organoids Market report typically cover these key segments-

  • 器官类型 (肠, 肝, 胃, 胰腺, 肺, 脑, 肾)
  • 应用 (生物疾病研发, 传染病病理学, 再生医学, 药物研发及个性化医疗, 药物毒性及疗效测试)
  • 来源 (多能干细胞, 器官特异性成体干细胞)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Organoids Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Organoids Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa Organoids Market?

    The Middle East & Africa Organoids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Cellesce
  • InSphero
  • Merck KGaA
  • STEMCELL Technologies Inc
  • Thermo Fisher Scientific Inc
  • Who should buy this report?

    The Middle East & Africa Organoids Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Organoids Market value chain can benefit from the information contained in a comprehensive market report.